The role of fascin in the migration and invasiveness of malignant glioma cells

Neoplasia

Volumn 10, Issue 2, 2008, Pages 149-159

  Jeong, Hyun Hwang ^a,b   Smith, Christian A ^b   Salhia, Bodour ^c   Rutka, James T ^b  

^a Kyungpook National University School of Medicine   (South Korea)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FASCIN; SMALL INTERFERING RNA;

ARTICLE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; EX VIVO STUDY; EXTRACELLULAR MATRIX; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 39049136505     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.07909     Document Type: Article

References (56)

1. Burger PC, Vogel FS, Green SB, and Strike TA (1985). Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56 (5), 1106-1111.
2. Stupp R, Hegi ME, Gilbert MR, and Chakravarti A (2007). Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol 25 (26), 4127-4136.
3. Soffietti R, Leoncini B, and Ruda R (2007). New developments in the treatment of malignant gliomas. Expert Rev Neurother 7 (10), 1313-1326.
4. Goffman TE, Dachowski LJ, Bobo H, Oldfield EH, Steinberg SM, Cook J, Mitchell JB, Katz D, Smith R, and Glatstein E (1992). Long-term follow-up on National Cancer Institute Phase I/II study of glioblastoma multiforme treated with iododeoxyuridine and hyperfractionated irradiation. J Clin Oncol 10 (2), 264-268.
5. Senger D, Cairncross JG, and Forsyth PA (2003). Long-term survivors of glioblastoma: statistical aberration or important unrecognized molecular subtype? Cancer J 9 (3), 214-221.
6. Giese A, Rief MD, Loo MA, and Berens ME (1994). Determinants of human astrocytoma migration. Cancer Res 54 (14), 3897-3904.
7. Giese A, Bjerkvig R, Berens ME, and Westphal M (2003). Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21 (8), 1624-1636.
8. Demuth Tand Berens ME (2004). Molecular mechanisms of glioma cell migration and invasion. J Neurooncol 70 (2), 217-228.
9. Lauffenburger DA and Horwitz AF (1996). Cell migration: a physically integrated molecular process. Cell 84 (3), 359-369.
10. Adams JC (2004). Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol 16 (5), 590-596.
11. Bartles JR (2000). Parallel actin bundles and their multiple actin-bundling proteins. Curr Opin Cell Biol 12 (1), 72-78.
12. Cohan CS, Welnhofer EA, Zhao L, Matsumura F, and Yamashiro S (2001). Role of the actin bundling protein fascin in growth cone morphogenesis: localization in filopodia and lamellipodia. Cell Motil Cytoskeleton 48 (2), 109-120.
13. Kureishy N, Sapountzi V, Prag S, Anilkumar N, and Adams JC (2002). Fascins, and their roles in cell structure and function. Bioessays 24 (4), 350-361.
14. Salhia B, Rutten F, Nakada M, Beaudry C, Berens M, Kwan A, and Rutka JT (2005). Inhibition of Rho-kinase affects astrocytoma morphology, motility, and invasion through activation of Rac1. Cancer Res 65 (19), 8792-8800.
15. Vignjevic D, Kojima S, Aratyn Y, Danciu O, Svitkina T, and Borisy GG (2006). Role of fascin in filopodial protrusion. J Cell Biol 174 (6), 863-875.
16. Kane RE (1975). Preparation and purification of polymerized actin from sea urchin egg extracts. J Cell Biol 66 (2), 305-315.
17. Cant K, Knowles BA, Mooseker MS, and Cooley L (1994). Drosophila singed, a fascin homolog, is required for actin bundle formation during oogenesis and bristle extension. J Cell Biol 125 (2), 369-380.
18. Mosialos G, Yamashiro S, Baughman RW, Matsudaira P, Vara L, Matsumura F, Kieff E, and Birkenbach M (1994). Epstein-Barr virus infection induces expression in B lymphocytes of a novel gene encoding an evolutionarily conserved 55-kilodalton actin-bundling protein. J Virol 68 (11), 7320-7328.
19. Edwards RA and Bryan J (1995). Fascins, a family of actin bundling proteins. Cell Motil Cytoskeleton 32 (1), 1-9.
20. Adams JC (1995). Formation of stable microspikes containing actin and the 55 kDa actin bundling protein, fascin, is a consequence of cell adhesion to thrombospondin-1: implications for the anti-adhesive activities of thrombospondin-1. J Cell Sci 108 (Pt 5), 1977-1990.
21. Adams JC (1997). Characterization of cell-matrix adhesion requirements for the formation of fascin microspikes. Mol Biol Cell 8 (11), 2345-2363.
22. Adams JC, Kureishy N, and Taylor AL (2001). A role for syndecan-1 in coupling fascin spike formation by thrombospondin-1. J Cell Biol 152 (6), 1169-1182.
23. Yamashiro-Matsumura S and Matsumura F (1986). Intracellular localization of the 55-kD actin-bundling protein in cultured cells: spatial relationships with actin, alpha-actinin, tropomyosin, and fimbrin. J Cell Biol 103 (2), 631-640.
24. Grothey A, Hashizume R, Ji H, Tubb BE, Patrick CW Jr, Yu D, Mooney EE, and McCrea PD (2000). C-erbB-2/HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines. Oncogene 19 (42), 4864-4875.
25. Grothey A, Hashizume R, Sahin AA, and McCrea PD (2000). Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer. Br J Cancer 83 (7), 870-873.
26. Jawhari AU, Buda A, Jenkins M, Shehzad K, Sarraf C, Noda M, Farthing MJ, Pignatelli M, and Adams JC (2003). Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol 162 (1), 69-80.
27. Pelosi G, Pastorino U, Pasini F, Maissoneuve P, Fraggetta F, Iannucci A, Sonzogni A, De Manzoni G, Terzi A, Durante E, et al. (2003). Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer 88 (4), 537-547.
28. Hashimoto Y, Ito T, Inoue H, Okumura T, Tanaka E, Tsunoda S, Higashiyama M, Watanabe G, Imamura M, and Shimada Y (2005). Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin Cancer Res 11 (7), 2597-2605.
29. Hashimoto Y, Skacel M, Lavery IC, Mukherjee AL, Casey G, and Adams JC (2006). Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas. BMC Cancer 6, 241.
30. Kabukcuoglu S, Ozalp SS, Oner U, Bildirici K, Yalcin OT, Oge T, and Colak E (2006). Actin bundling protein fascin expression in ovarian neoplasms: comparison of histopathologic features of tumors obtained by the first and secondary cytoreduction surgeries. Eur J Gynaecol Oncol 27 (2), 123-128.
31. Zhang H, Xu L, Xiao D, Xie J, Zeng H, Cai W, Niu Y, Yang Z, Shen Z, and Li E (2006). Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma. J Clin Pathol 59 (9), 958-964.
32. Zigeuner R, Droschl N, Tauber V, Rehak P, and Langner C (2006). Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique. Urology 68 (3), 518-522.
33. Puppa G, Maisonneuve P, Sonzogni A, Masullo M, Chiappa A, Valerio M, Zampino MG, Franceschetti I, Capelli P, Chilosi M, et al. (2007). Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinoma. Br J Cancer 96 (7), 1118-1126.
34. Xie JJ, Xu LY, Zhang HH, Cai WJ, Mai RQ, Xie YM, Yang ZM, Niu YD, Shen ZY, and Li EM (2005). Role of fascin in the proliferation and invasiveness of esophageal carcinoma cells. Biochem Biophys Res Commun 337 (1), 355-362.
35. Peraud A, Mondal S, Hawkins C, Mastronardi M, Bailey K, and Rutka JT (2003). Expression of fascin, an actin-bundling protein, in astrocytomas of varying grades. Brain Tumor Pathol 20 (2), 53-58.
36. Roma AA and Prayson RA (2005). Fascin expression in 90 patients with glioblastoma multiforme. Ann Diagn Pathol 9 (6), 307-311.
37. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, and Tuschl T (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (6836), 494-498.
38. Sriramarao P, Mendler M, and Bourdon MA (1993). Endothelial cell attachment and spreading on human tenascin is mediated by alpha 2 beta 1 and alpha v beta 3 integrins. J Cell Sci 105 (Pt 4), 1001-1012.
39. Berens ME, Rief MD, Loo MA, and Giese A (1994). The role of extracellular matrix in human astrocytoma migration and proliferation studied in a microliter scale assay. Clin Exp Metastasis 12 (6), 405-415.
40. Valster A, Tran NL, Nakada M, Berens ME, Chan AY, and Symons M (2005). Cell migration and invasion assays. Methods 37 (2), 208-215.
41. Ohnishi T, Matsumura H, Izumoto S, Hiraga S, and Hayakawa T (1998). A novel model of glioma cell invasion using organotypic brain slice culture. Cancer Res 58 (14), 2935-2940.
42. Jung S, Ackerley C, Ivanchuk S, Mondal S, Becker LE, and Rutka JT (2001). Tracking the invasiveness of human astrocytoma cells by using green fluorescent protein in an organotypical brain slice model. J Neurosurg 94 (1), 80-89.
43. Nakada M, Niska JA, Miyamori H, McDonough WS, Wu J, Sato H, and Berens ME (2004). The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells. Cancer Res 64 (9), 3179-3185.
44. Rutka JT, Muller M, Hubbard SL, Forsdike J, Dirks PB, Jung S, Tsugu A, Ivanchuk S, Costello P, Mondal S, et al. (1999). Astrocytoma adhesion to extracellular matrix: functional significance of integrin and focal adhesion kinase expression. J Neuropathol Exp Neurol 58 (2), 198-209.
45. De Arcangelis A, Georges-Labouesse E, and Adams JC (2004). Expression of fascin-1, the gene encoding the actin-bundling protein fascin-1, during mouse embryogenesis. Gene Expr Patterns 4 (6), 637-643.
46. Edwards RA, Herrera-Sosa H, Otto J, and Bryan J (1995). Cloning and expression of a murine fascin homolog from mouse brain. J Biol Chem 270 (18), 10764-10770.
47. Kabukcuoglu S, Ozalp SS, Oner U, Acikalin MF, Yalcin OT, and Colak E (2005). Fascin, an actin-bundling protein expression in cervical neoplasms. Eur J Gynaecol Oncol 26 (6), 636-641.
48. Rodriguez-Pinilla SM, Sarrio D, Honrado E, Hardisson D, Calero F, Benitez J, and Palacios J (2006). Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas. Clin Cancer Res 12 (5), 1533-1539.
49. Zhang S, Lin QD, and Di W (2006). Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1. Int J Gynecol Cancer 16 (2), 522-531.
50. Chen SF, Yang SF, Li JW, Nieh PC, Lin SY, Fu E, Bai CY, Jin JS, Lin CY, and Nieh S (2007). Expression of fascin in oral and oropharyngeal squamous cell carcinomas has prognostic significance - a tissue microarray study of 129 cases. Histopathology 51 (2), 173-183.
51. Ono S, Yamakita Y, Yamashiro S, Matsudaira PT, Gnarra JR, Obinata T, and Matsumura F (1997). Identification of an actin binding region and a protein kinase C phosphorylation site on human fascin. J Biol Chem 272 (4), 2527-2533.
52. Adams JC, Clelland JD, Collett GD, Matsumura F, Yamashiro S, and Zhang L (1999). Cell-matrix adhesions differentially regulate fascin phosphorylation. Mol Biol Cell 10 (12), 4177-4190.
53. Wong V, Ching D, McCrea PD, and Firestone GL (1999). Glucocorticoid down-regulation of fascin protein expression is required for the steroid-induced formation of tight junctions and cell-cell interactions in rat mammary epithelial tumor cells. J Biol Chem 274 (9), 5443-5453.
54. Vignjevic D, Schoumacher M, Gavert N, Janssen KP, Jih G, Lae M, Louvard D, Ben-Ze'ev A, and Robine S (2007). Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res 67 (14), 6844-6853.
55. Liu G, Ying H, Zeng G, Wheeler CJ, Black KL, and Yu JS (2004). HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells. Cancer Res 64 (14), 4980-4986.
56. Koka V, Potti A, Forseen SE, Pervez H, Fraiman GN, Koch M, and Levitt R (2003). Role of Her-2/neu overexpression and clinical determinants of early mortality in glioblastoma multiforme. Am J Clin Oncol 26 (4), 332-335.